Women and Endothelial Dysfunction

                
Prevention magazine selected EndoPAT among top medical breakthroughs

            View all publications

Women And Endothelial Dysfunction

Although ischemic heart disease (IHD) is often considered a “man’s disease,” it takes the lives of more women than men each year. In fact, it’s estimated that about 60,000 more women than men die from cardiovascular disease annually in the United States.

Landmark research now reports that women’s disease is actually very different from that typically found in men, with a variety of complex underlying factors. Further, because women’s ischemic disease often evades detection through traditional diagnostic techniques that are based on men’s disease, it may continue to cause symptoms but remain undiagnosed until progressing to a critical stage.

Typical Scenario

All too often, many physicians are presented with the following scenario: A woman comes into the office complaining of chest pain, undergoes a stress test to evaluate the chest pain, and the stress test results suggest coronary artery disease. She is then referred for a test called an angiogram to look at her coronary arteries. Despite her symptoms and the abnormal stress test, she is told that the angiogram didn’t find anything of clinical significance and she is sent home without treatment.

However, a new study may change this by offering greater insight into the causes behind chest pain in women and how it manifests differently in women than it does in men.

The study, published in the Archives of Internal Medicine (Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease; Arch Intern Med. 2009;169(9):843-850.), reports that women with chest pain but without coronary artery disease are at an elevated risk for cardiovascular events such as heartattack or stroke.

“These results combined with prior work suggest that women are not just smaller versions of men when it comes to heart disease,” said C. Noel Bairey Merz, M.D., director of the Women’s Heart Center at the Cedars-Sinai Heart Institute and the chair of the Women’s Ischemia Syndrome Evaluation (WISE) study. Sponsored by the National Heart Lung and Blood Institute, the WISE studies began in 1997 and have since pointed out how differently men and women experience symptoms of coronary heart disease.

Dr. Bairey Merz has an EndoPAT and has been advising Itamar over the years on heart-related medical issues.

Women Are Different Than Men

Heart disease is not gender neutral, according to the landmark WISE findings. Women and men experience heart disease differently and require different treatments. “Our findings challenge the accepted belief in the medical community that these patients should be considered low-risk, and points towards the need for a different treatment regimen for these patients moving forward,” said Martha Gulati, M.D., first author of the study, cardiologist, and associate director of the Center for Women’s Cardiovascular Health at Northwestern Memorial’s Bluhm Cardiovascular Institute.

The study analyzed data from two previous studies—the WISE study and the St. James Women Take Heart project—to complete the review. The WISE study examined symptomatic women referred for coronary angiography, or an X-ray examination of the blood vessels or chambers of the heart, and followed them for about five years.

The Women Take Heart project enrolled asymptomatic, community-based women with no history of heart disease who were followed for up to 10 years. The prospective study compares cardiovascular events such as heart attack, stroke, and hospitalization for heart failure, in 540 WISE study participants with suspected ischemia, but no evidence from medical tests, with those from a group of 1,000 age and race-matched Women Take Heart women.

Compared with the WISE women, the Women Take Heart women had a lower prevalence of obesity, family history of coronary artery disease, hypertension, and diabetes. Results showed that over the course of five years, the WISE women had more cardiac events than the Women Take Heart women. The women who experienced the most frequent cardiovascular events were those with four or more cardiac risk factors.

Check For Endothelial Dysfunction

The physicians hypothesize that this difficult-to-diagnose chest pain could be caused by microvascular angina and endothelial dysfunction, affecting blood vessels in which the layers of the cells are not functioning properly and may be undetectable by standard testing.

Researchers believe endothelial dysfunction to be the earliest stage of coronary artery disease—the risk of the risk factors.

The study authors recommend:

Women with chest pain symptoms should undergo initial testing for coronary artery disease.
If there is no evidence of coronary artery disease, patients should undergo further assessment for endothelial dysfunction.
If detected, patients should then undergo treatment to improve the dysfunction. The EndoPAT is the only FDA-approved device for this 15-minute in-office procedure.
Women with symptoms, but no presence of endothelial dysfunction, should work with physicians to aggressively modify certain risk factors for heart disease, such as smoking, weight control, and cholesterol.

How The EndoPAT Test Works

What's Your EndoScore?

Dr. Near You